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Viruses attach  to cells via specialized attachment  proteins  that  interact  with 
specific cell  surface receptors  (1-5).  An  understanding  of such virus-host  cell 
interactions  may provide new insights  into the pathogenesis and prevention of 
infectious diseases (6). 
The mammalian reoviruses, segmented, double-stranded RNA viruses include 
three serotypes (7). The segmented nature of the reovirus genome has permitted 
a  genetic approach for the identification  of the role of individual  viral compo- 
nents in pathogenesis, making the study of virus-host interactions more amenable 
to direct experimentation (8). These studies have revealed that each of the three 
outer capsid proteins (#lc, ~1, ~r3) plays critical, distinct roles in viral virulence. 
One of the outer capsid proteins, al, the reovirus hemagglutinin (HA), ~ has been 
shown to be the reovirus cell attachment protein (9-12). Studies utilizing mono- 
clonal antibodies have revealed that the HA is divided into three distinct domains 
(13,  14),  one  of which  governs  the  important  biologic properties  of receptor 
interaction,  recognition  by cytotoxic T  lymphocytes (CTL) and recognition by 
neutralizing  antibody (15,  17). Reovirus mutants at this site, selected for resist- 
ance to neutralization,  are altered  in cell  tropism  (in  the  nervous  system) (16) 
and in recognition by CTL (17).  Therefore,  monoclonal antibodies directed to 
this site, block a number of important biologic properties of reovirus. 
That such diverse biologic properties as CTL recognition and viral neutrali- 
zation  localize  to one part  of the  HA suggests that  binding  is  restricted  by a 
unique  conformation  or,  alternatively,  by a  set  of epitopes on  the  HA.  This 
implies that the receptor for virus on immune CTL, the natural receptor found 
on  neurons,  and  the  binding  moiety  of neutralizing  monoclonal  antibodies 
(idiotype) share a common configuration as well. 
To test this possibility,  syngeneic monoclonal  antibodies were raised against 
the  idiotype portion  of a  prototypic  neutralizing  monocional  antibody,  9BG5 
(18,  19). The antiidiotype obtained has been shown to block both viral binding 
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tO  neuronal  cells  (18)  and  CTL  lysis  of virally  infected  target  cells. 2  These 
findings  further  reinforced  the  hypothesis  that  the  antiidiotype  functionally 
resembles the viral HA. To further explore the similarities of this antiidiotypic 
antibody to HA, we have asked whether  the antiidiotype can directly stimulate 
antiviral  immunity,  serving  as  a  noninfectious  mimic  of virus  in  vivo.  In  this 
paper we show  that  purified  monoclonal  antiidiotypic  antibodies  can stimulate 
reovirus-specific delayed  type  hypersensitivity  (DTH) and  CTL  responses  in  a 
dose-dependent and hemagglutinin-restricted  fashion. 
Materials and  Methods 
Mice.  BALB/c (H-2a; Igh-1 ~) and C3H/HeJ (H-2k; Igh-1  j) female mice, 6-8 wk of age, 
were  obtained  from  The Jackson  Laboratory,  Bar  Harbor,  ME,  and  maintained  on 
standard  lab chow and  water ad libitum.  Mice were  tested  for antireovirus antibodies 
before immunization and were found to be free of antibodies by enzyme-linked immu- 
nosorbent assay (ELISA), radioimmunoassay (RIA), and neutralization testing (11). 
Virus.  Reovirus type 1 (strain  Lang), type 3 (strain Dearing), and reassortant viruses 
1.HA3 and 3.HA 1 have been described previously (12, 20). Reassortant 1.HA3 contains 
nine dsRNA segments from reovirus type 1 and the S 1 genome segment from reovirus 
type 3. Reassortant 3.HA 1 contains nine dsRNA segments from reovirus type 3 and the 
SI dsRNA segment from type 1. The variant virus K, selected by resistance to neutrali- 
zation with the 9BG5 monoclonal antibody, has been described previously (15). All viruses 
were grown and titered  in  mouse L929  cells as described previously (21) and purified 
according  to  the  method  of  Drayna  and  Fields  (22).  All  purified  viral  stocks  were 
administered to animals in gelatin-containing buffered saline as described previously (23). 
Cells.  P815  (H-2  d)  mastocytoma cells were  maintained  in  vivo by serial  passage as 
ascites  in  BALB/c  mice and  in  vitro  in  Dulbecco's  modified  Eagle's medium  (DME) 
supplemented with  10% fetal calf serum (M. A. Bioproducts, Waikersville, MD), 10 mM 
glutamine (Irvine Scientific, Santa Ana, CA). 
87.92.6 is a B cell hybridoma that is specific for the idiotype of the antireovirus type 3 
HA hybridoma 9BG5 (18). The 87.92.6 cell line, which secretes an IgM, kappa monoclonal 
antibody, was maintained in HBI01 synthetic media plus HB101 serum-free supplement 
(Hanna Labs, Berkeley, CA). 
Purification  of Monoclonal  Antiidiotype.  Cell-free supernatants of 87.92.6  cells grown 
in HB 101 synthetic media were first pooled and concentrated on an Amicon ultrafiltration 
cell (Amicon Corporation,  Danvers,  MA)  with a  Type C-100  membrane (Nucleopore, 
Pleasanton,  CA) and then sequentially precipitated three times at 30-50%  ammonium 
sulfate. The resulting precipitate was dissolved in phosphate-buffered saline (PBS)  and 
extensively dialyzed against PBS at 4 ° C. After dialysis was complete, antibody was adjusted 
to 20 mM phosphate (pH 7.2), 0.5 M NaCl, and  1% n-butanol and IgM was purified by 
Sephadex G-200 column chromatography. Eluate fractions from the void volume were 
shown to contain >95% antiidiotype IgM by SDS-PAGE, isoelectric focusing (IEF), and 
Ouchterlony analysis. Protein concentration of purified antiidiotype was determined by 
the method of Bradford (24). 
Immunization of Mice.  For DTH experiments, mice were inoculated  subcutaneously 
(s.c.) in two separate sites on the dorsal flanks of the animal (over each hind limb). For 
immunizations with virus, animals were inoculated with 107 particles of virus/0.2 ml given 
as two separate injections of 0.1  ml.  For immunization with antiidiotype, animals were 
inoculated with varying amounts of antiidiotype given in two separate injections of 0.1  ml 
on day 0 and day 2. All animals were challenged 6 d after initial immunization in the left 
footpad with 25 #1 of gelatin saline containing a total of 3 ×  107 viral particles. Footpad 
swelling was measured 24 h later (except when time course studies were performed) in a 
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blind  fashion  using  a  Fowler  micrometer  (Schelinger's,  Brooklyn,  NY). Four  or  five 
animals per group were studied and the magnitude of the response was expressed as the 
increment of thickness of the challenged  left footpad, as compared to the untreated right 
footpad. 
For CTL experiments,  animals  were immunized  intraperitoneally  with  107  plaque- 
forming units  (pfu) of reovirustype 3 or with antiidiotype (~100 ~tg) or with gamma- 
irradiated 87.92.6 cells (3 ×  10  cells/animal)  given to each animal  twice (on day 0 and 
day 2).  1 wk later, splenocytes  were harvested and  incubated in  24-well Costar dishes 
(Costar,  Cambridge, MA) with  107 pfu of virus per well in a total volume of 1.6 ml of 
DME supplemented with 2% fetal calf serum, glutamine,  and 2-mercaptoethanol (7 X 106 
splenocytes/well).  Cells were harvested 5 d  later, purified over Ficoll-Isopaque  (Litton 
Bionetics, Kensington,  MD), and tested in a 5-h 5~Cr-release assay on 5~Cr-labeled P815 
cells,  reovirus  type  3-infected  P815  cells,  and  87.92.6  cells  as  targets,  as  described 
previously (25). 
Adoptive Transfer Experiments.  For transfer experiments, mice were inoculated with 
107 viral particles/0.4 ml or with antiidiotype (~ 100 #g protein),  given in four separate 
sites on the back of the animal  (over hind limbs and forelimbs).  5 d after subcutaneous 
immunization,  the draining lymph nodes were removed and a single cell suspension  was 
prepared as described previously (21). Syngeneic recipients  received 1 x  10  s cells injected 
intravenously and were simultaneously  primed with 3 x  107 particles of virus. 
Anti-Thy-l.2 Treatment.  Anti-mouse  Thy-l.2 antisera  (source) and guinea pig comple- 
ment  (C) treatment  was performed on sensitized  lymph  node cells before transfer as 
reported previously (23). 
Results 
Monoclonal Antiidiotype  Can Elicit a DTH Response  to Reovirus.  To determine 
whether immunization of mice with purified monoclonal antiidiotype could elicit 
an antiviral  immune response for DTH, animals were immunized  with  100 #g 
s.c. of antiidiotype or saline and challenged in the footpad with 3 ×  107 particles 
of  reovirus  type  3  or  type  1.  After  preliminary  studies  demonstrated  that 
antiidiotype could elicit footpad swelling in response to reovirus type 3, footpad 
swelling was measured every 4 h  from 4  to 32 h after challenge and at 48 and 
72 h  after challenge.  As seen  in  Fig.  1,  footpad swelling began  by  12  h  after 
challenge,  peaked  at  28  h  after  challenge,  and  disappeared  by  72  h  after 
challenge.  The  kinetics of this response are,  thus,  characteristic  of the delayed 
hypersensitivity reaction arid identical  in mice primed with either reovirus type 
3 or antiidiotype and  challenged  with reovirus type 3.  Furthermore,  the peak 
response observed in mice immunized with antiidiotype was 75% of that of mice 
primed  with  reovirus  type  3.  Characteristic  findings  of DTH  response  were 
observed histologically in animals exhibiting footpad swelling. 
Adoptive  Transfer  of Antiidiotype-elected  DTH  to  Reovirus  by  Thymus-derived 
Cells.  To define the cellular nature of the antiidiotype-induced DTH response 
to  reovirus,  adoptive  transfer  experiments  were  performed.  Draining  lymph 
nodes were removed from BALB/c mice 6 d  after repeated immunization  with 
antiidiotype and single-cell suspensions were prepared and transferred to naive 
BALB/c  recipients  intravenously  (108  cell/mouse).  Recipient  mice  were  chal- 
lenged in the footpad at the time of transfer and footpad swelling was measured 
24 h  later.  Thy-l.2  cells were removed by treatment  with anti-Thy-l.2  mono- 
clonal antibody plus complement before transfer (27). 
As  shown  in  Fig.  2,  complement-treated  lymph  node  cells  from  animals 
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FIGURE 1.  Time course  of DTH  with reovirus  tyl~e 3  and  the  antiidiotypic  antibody. 
BALB/c mice were immunized subcutaneously with 10' particles of reovirus type 3 or 100 ~g 
of purified monoclonal antiidiotypic antibody on day 0 and challenged with reovirus 6 d later. 
Footpad swelling was measured at various times after challenge. 
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FIGURE 2.  Adoptive transfer of antiidiotype-induced  DTH by T  cells. BALB]c mice were 
immunized subcutaneously with  100 #g of purified  monoclonal antiidiotypic antibody and 
lymph nodes  were removed 6 d after immunization.  Naive BALB/c mice received either 
complement-treated  immune lymph node cells, immune lymph node cells treated with anti- 
Thy-1.2 plus complement, antiidiotype-immune serum, or saline. Immediately after transfer, 
animals were challenged with reovirus type 3. Foodpad swelling was measured 24 h later. 
secondary recipients. The immune cells responsible for adoptive transfer of DTH 
are T  cells, since the ability to transfer immune reactivity was abrogated by anti- 
Thy-l.2 plus C  treatment. The inability of reovirus type 3 hyperimmune sera to 
transfer responses is also shown. Thus, monoclonal antiidiotype induces a T  cell- 
dependent immune response that recognizes reovirus type 3. 
DTH Response Elicited by the Monoclonal  Antiidiotype Is Spec~c for the Neutrali- 
zation Domain of the Reovirus  Type 3 HA.  Previous studies have shown that  the 
DTH  response to reovirus is serotype-specific and that the viral HA determines 
serotype  specificity  (23).  To  determine  the  specificity  of  the  DTH  response 
elicited by the monoclonal antiidiotype, animals were immunized with 100 ~g of 
antiidiotype, boosted with an additional  100 ~g 2  d  later, and challenged in the 
footpad on  day 6  with  reovirus type  I, type  3,  the  reassortant  viruses  1.HA  3 
and 3.HA  1, and the variant virus, K. 
The  results  presented  in  Fig.  3  indicate  that  the  DTH  response  elicited  by SHARPE  ET  AL.  1 199 
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FIGURE 3.  Specificity of the  DTH  response elicited by  the  monodonal  antiidiotype. 
BALB/c  mice  were immunized  with  100 #g s.c.  of antiidiotype,  boosted  with an additional 
100 t~g 2 d later, and challenged in the foodpad on day 6 with either reovirus type 3, type I, 
reassortant  I.HA3,  reassortant  3.HA1, variant virus  K,  or  saline.  Footpad  swelling  was 
measured 24 h later. Results are expressed as a percentage of the DTH response (+SEM) in 
mice primed and challenged  with reovirus type 3. For Reo 1, 3HA1, variant K, and saline, 
P < 0.001. For Reo 3 and 1HA3, P < 0.01. 
monoclonal antiidiotype is serotype specific and is mediated by the viral HA. A 
DTH response was observed in animals challenged with reovirus type 3 and with 
the reassortant 1.HA3 that contains the type 3 S1 dsRNA segment (HA) and the 
remaining nine dsRNA segments from type  1 reovirus. In both instances, the 
magnitude of the  DTH  response was  ~80%  of the response elicited in  mice 
primed and challenged with reovirus type 3.  In contrast, mice challenged with 
type 1 reovirus and the reciprocal reassortant 3.HA 1 exhibited little or no DTH 
response. For these mice, footpad swelling was similar to that observed in control 
mice immunized with gelatin-saline and challenged with type 3 reovirus. 
Recently, reovirus type 3 viruses with antigenically altered HA proteins have 
been generated. These viruses, selected by their capacity to grow in the presence 
of the  neutralizing  monoclonal  antibody  9BG5,  have  been  designated  viral 
"variants." Because the antiidiotype is directed against the 9BG5  neutralizing 
monoclonal antibody, it was of interest to determine the HA domain specificity 
of the antiidiotype-induced response. When antiidiotype-primed mice were chal- 
lenged with reovirus type 3 or the K variant, the magnitude of the DTH response 
was much lower in mice challenged with the K variant (Fig. 3). The magnitude 
of the DTH response to type 3 was ~75% of the response elicited in mice primed 
and challenged with reovirus type 3, whereas the response to variant k was only 
20%. Thus, antiidiotype induces an immune response that discriminates the type 
3  HA  neutralization domain from the  variant  HA epitope.  Interestingly, the 
DTH  response observed in  mice primed with type 3  and challenged with the 
variant virus K is 61% of the response seen in mice immunized and challenged 
with reovirus type 3. 
Effect of Dose of Antiidiotype on the Magnitude  of the DTH Response.  Animals 
were immunized subcutaneously with varying amounts of purified antiidiotype 
(0.1-10 #g) on day 0  and day 2 and challenged 6 d  after initial immunization 1200  SYNGENEIC  MONOCLONAL  ANTIIDIOTYPE 
with reovirus type 3. Control mice were immunized with equivalent amounts of 
an  irrelevant purified  IgM  Kappa  monoclonal antibody (HO  13.4)  or type 3 
reovirus.  A  reovirus-specific DTH  response  was  elicited even with  0.1  pg  of 
antiidiotype (8  ×  10 8 molecules).  The  magnitude of the  DTH  response  was 
dependent on the dose of antiidiotype in this concentration range (Fig.  4).  No 
response was observed in either immunization (HO  13.4) or challenge (reovirus 
type  1)  controls.  Thus,  the  purified  antiidiotype  induces  a  specific,  potent 
immune response to reovirus type 3. 
Effect of AUotype on the DTH Response.  To evaluate whether the Igh allotype 
of mouse strain was important for the antiidiotype-elicited DTH response, C3H/ 
HeJ (Igh-P) were primed with antiidiotype. As shown in Table I, C3H/HeJ and 
BALB/c mice were equivalently primed by antiidiotype. Thus, the Igh-1 allotype 
of recipients is  not relevant to  the ability of antiidiotype to  elicit an immune 
response. 
Antiidiotype-bearing Hybridoma Cells Can Elicit a CTL Response to Reovirus Type 
3.  To determine whether immunization of mice with antiidiotype could elicit 
an antiviral CTL response, animals were immunized subcutaneously with anti- 
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FIGURE 4.  Dose  response of antiidiotype on  magnitude of DTH  response.  BALB/c  mice 
were immunized s.c. with varying amounts of purified monoclonal antiidiotype or control and 
challenged in the footpad 6 d later with reovirus type 3 or type 1. 
TABLE  I 
Delayed Type Hypersensitivity Responses to the 87.92. 6 Monoclonal 
Antiidiotype in C3H/HeJ Mice 
Immunization  Challenge  Footpad swelling 
Type 3  Type 3  34.25 
87.92.6  Type 3  23.5 
87.92.6  Type 1  8.5 
87.92.6  3HA1  23.5 
87.92.6  1HA3  8.5 
Saline  Type 3  6.5 
The DTH  experiments were carried out as described in  Materials and 
Methods, using either reovirus type 3 or the syngeneic monoclonal anti- 
idiotype to immunize mice and reovirus type 1 or 3 or reassortants 1HA3 
or 3HA1  to challenge the mice. SHARPE  ET  AL.  1201 
idiotypic  antibody  or  with  irradiated  87.92.6  hybridoma  cells.  The  87.92.6 
hybridoma cell,  which  is an  early  B  cell and  expresses significant amounts of 
immunoglobulin on its surface, was utilized as a potential vehicle for immuniza- 
tion.  Initial attempts to immunize optimally with 87.92.6 antibody led to only 
minimal activation of antireovirus CTL activity. Immunization of animals with 
irradiated  87.92.6  cells elicited  vigorous CTL  activity against  reovirus.  1 wk 
after in vivo immunization with 3 ×  105 irradiated 87.92.6 cells, immune spleen 
cells were removed and incubated in vitro with reovirus type 3. Five days later, 
spleen cells were assayed for their capacity to kill reovirus-infected P815 cells. 
As seen in Fig. 5, 87.92.6-induced T  cells generated vigorous cytotoxic activity 
against reovirus-infected  target  cells,  but not against  noninfected target  cells, 
mirroring the effects of reovirus immunization. 
Discussion 
These studies show that purified monoclonal antiidiotypic antibody (87.92.6) 
induced by  monoclonal antibodies directed to the reovirus  HA  neutralization 
domain, can induce potent reovirus-specific T  cell immunity in the absence of 
adjuvant.  Syngeneic antiidiotype priming elicits potent transferable  T  cell im- 
munity to reovirus type 3 as measured by DTH responses in vivo. The magnitude 
of the  DTH  response  elicited  by  syngeneic  monoclonal antiidiotype  is  dose- 
dependent, and is specific for the neutralization domain of the reovirus type 3 
HA.  In  addition,  the  extent  of immune responsiveness to antiidiotype is  not 
restricted  by the  IgH  locus.  Antiidiotype also  induces potent  cytolytic T  cell 
activity  when  animals  are  first  primed  in  vivo with  monoclonal  antiidiotype- 
bearing hybridoma cells.  The failure  to efficiently prime for cytolytic activity 
with soluble protein contrasts with the effective stimulation of inflammatory cells 
40 
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FIGURE 5.  CTL  response elicited by the antiidiotype-bearing hybridoma cells 87.92.6,  to 
reovirus  type  3.  BALB/c  mice  were  primed  subcutaneously with  (A)  87.92.6  cells or  (B) 
reovirus type 3.  Immune spleen cells were removed  1 wk later and incubated in vitro with 
reovirus type 3 for 5 d. The capacity of splenocytes to kill reovirus type 3-infected P815 cells 
(P815.3) versus noninfected P815 cells (P815N) were compared using a 5-h ~lCr-release assay. 
Results are presented as the mean of triplicate experiments. 1202  SYNGENEIC  MONOCLONAL  ANTIID1OTYPE 
by antibody alone. This may relate to the different type of histocompatibility- 
associated signals required for activation of these distinct sets of cells.  Cytolytic 
T  cell precursors are stimulated by antigen in conjunction with major histocom- 
patibility  complex  (MHC)  components.  The  antiidiotype-bearing hybridomas 
express both antiidiotype and both class  I and II MHC components on the cell 
surface, and thereby may be more effective stimulators of CTL than antibody 
alone. Alternatively, the affinity of the antiidiotypic antibody for reovirus-specific 
receptors on the cytolytic cells may be different from the receptors used by T 
cells that  mediate inflammation. This  latter possibility is difficult to reconcile 
with the efficiency of priming for either DTH or CTL activities by virus (17, 
23). Thus, monoclonal anti-HA antiidiotype mimics the reovirus HA in both the 
extent and specificity of immune responsiveness.  These results are consistent 
with  previously  observed  antiidiotype  mimicry of viral  binding  and  cellular 
activities (18-20, 28). 
Manipulation of the immune response by injection of antibodies to idiotypes 
has been used in several systems (28-31).  In these studies exposure to antigen 
after the injection of antiidiotypic reagents resulted in either suppression of the 
idiotype-bearing antigen-binding molecule or increased idiotype expression and 
antigen-binding activity, depending upon the route of injection. Recently, Ken- 
nedy and  Dreesman (32)  have shown that rabbit  antiidiotypic antibody could 
prime BALB/c mice for the generation of antibody to hepatitis B surface antigen 
(HbsAg) if the mice were secondarily boosted with HbsAg or antiidiotype. The 
evaluation of cellular responses was, however, not reported. Ertl et al. (33) have 
used a  crude monoclonal anti-T  cell receptor antibody supernatant to  prime 
mice for  reactivity to  Sendai  virus.  However,  the  idiotypic specificity of the 
antiviral response is not well-characterized in that system. In contrast, the purified 
monoclonal antiidiotype  in  the  reovirus system detects  idiotopes  on  anti-HA 
antibodies specific for the neutralization domain of the HA. The 87.92.6 mono- 
clonal antiidiotype was generated by  priming  BALB/c  mice with  a  BALB/c- 
induced monoclonal antibody 9BG5.  Hence, the use of the monoclonal antiidi- 
otype 87.92.6  in inducing immune responses in BALB/c mice is equivalent to 
priming with self structures as suggested originally by Jerne (34).  Using antiidi- 
otypic  antibody  protein  purified  to  homogeneity we  showed  that  8  x  108 
molecules were able to prime for cellular responses to reovirus. To our knowl- 
edge, this is the first demonstration of the effectiveness of pure antibody protein 
in the absence of adjuvant in eliciting antiviral immunity. 
Taken together, these results indicate that antiidiotypic reagents provide an 
attractive means for modulating the immune response.  The strategy of using 
antiidiotypes for  inducing or  augmenting immunity to  viral  diseases  without 
direct exposure of the host to the pathogen is advantageous in the development 
of an immunologic vaccine for protection against lethal viruses. Further studies 
with antiidiotypic reagents should provide insight into the uses of these reagents 
to manipulate immune responses in order to provide protection of hosts from 
infectious agents without the risks of current vaccine approaches.  Preliminary 
experiments indicate that polymerized syngeneic monoclonal antiidiotype protein 
can induce neutralizing antibodies to the mammalian reovirus. SHARPE ET  AL.  1203 
Summary 
A syngeneic monoclonal antiidiotypic antibody was generated in BALB/c mice 
after repeated immunization with a BALB/c monoclonal anti-reovirus hemagglu- 
tinin (HA) antibody. The resultant syngeneic monoclonal antiidiotypic antibody, 
in the absence  of adjuvant, was found to be capable of priming both BALB/c 
(H-2 d, Igh-1 a) and C3H/Hej (H-2 k, Igh-1  j) mice for Lyt-1  +- and Lyt-2+-dependent 
responses against the mammalian reovirus. By the use of intertypic reassortants 
and variant virus analysis, the specificity of the response was finely mapped to 
the  neutralization  domain  of  the  viral  hemagglutinin  (HA).  Using  purified 
monoclonal antiidiotype, we were able to compare the potency of antiidiotype 
to virus in terms of induction of immunity. 8 x  10 a protein molecules were able 
to prime  for cellular responses to reovirus.  These  studies indicate that in  the 
reovirus  system,  T  cells  and  B  cells  share  idiotypic configurations,  and  that 
antiidiotypic  antibodies  of  the  type  described  herein  may  be  useful  in  the 
development of vaccines against certain viral infections. 
We thank Cynthia Sobotka for excellent technical assistance  and Rosemary Bacco  for 
preparation of this manuscript. 
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